TGFB1 and silicosis: In recent years [17], silicosis treatment study from the molecular level is also increasing, such as TGF-β [18], as the key active factor of silicosis fibrosis, which can be induced by P38 splitting the original activating protease (mitogen activated protein kinase, MAPK) signaling pathway activation and exert its biological effect [6].